Pharmafile Logo

VJOncology

Bristol-Myers Squibb (BMS) building

Opdivo gains new US lung cancer licence

Adds to Bristol-Myers Squibb’s therapeutic vaccine’s melanoma indication

- PMLiVE

Digital health charge led by millennials in the US

But older patients more likely to use pharma sites if directed by a doctor

Build your e-detailing argumentation

We’ve written a number of posts recently giving insights into the Anthill method for structuring e-detailing & CLM presentations. To help you overview, we’ve put these argumentation posts together.

Anthill Agency

- PMLiVE

Adaptimmune appoints former GSK executives

Dr Rafael Amado and Adrian Rawcliffe join the biotech’s top ranks

- PMLiVE

Campaigns improve cancer symptom awareness, claims BJC

Has shown an increase in GP visits for possible cancer symptoms

- PMLiVE

AbbVie to acquire cancer biopharma Pharmacyclics for $21bn

Comes six months after the US firm pulled out of a $54bn deal with Shire

- PMLiVE

Nikon expands into healthcare and buys retinal tech firm

Japanese camera and technology company spends big on Scotland’s Optos

- PMLiVE

SEC calls for greater disclosure from pharma

Claims companies are leaving themselves open to enforcement action

- PMLiVE

Healthcare boundaries ‘being erased,’ says PwC

Reports claims technology is eradicating person-to-person interaction

FDA launches drug shortages mobile app

USregulator offers the public and HCPs Android and iPhone versions of the app

- PMLiVE

Former Tonic directors launch Iris Life Communications

Stéphanie Bunten and Lee-Ann Cameron's new agency will be based in London's Shoreditch

- PMLiVE

NHSA awarded £2.9m to boost life and health sciences

Funding will support operations in the north of England for five years

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links